Sippican Capital Advisors’s Organon & Co OGN Stock Holding History

Sippican Capital Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-70,076	Closed	-$1.04M	–	113
2025 Q1	$1.04M	Buy	70,076 +33,724	+93%	+$519K	0.79%	51
2024 Q4	$542K	Buy	36,352 +21,122	+139%	+$344K	0.4%	79
2024 Q3	$291K	Buy	15,230 +627	+4%	+$13K	0.2%	91
2024 Q2	$302K	Buy	14,603 +721	+5%	+$14.3K	0.24%	91
2024 Q1	$261K	Buy	+13,882	New	+$238K	0.2%	97
2023 Q4	–	Sell	-99,232	Closed	-$1.72M	–	119
2023 Q3	$1.72M	Buy	99,232 +16,320	+20%	+$340K	1.56%	22
2023 Q2	$1.73M	Buy	82,912 +17,197	+26%	+$374K	1.59%	18
2023 Q1	$1.55M	Buy	65,715 +12,625	+24%	+$339K	1.48%	22
2022 Q4	$1.48M	Buy	53,090 +2,465	+5%	+$63K	1.42%	23
2022 Q3	$1.19M	Buy	50,625 +11,507	+29%	+$347K	1.24%	33
2022 Q2	$1.32M	Buy	39,118 +233	+0.6%	+$8.16K	1.31%	31
2022 Q1	$1.36M	Buy	38,885 +18,389	+90%	+$629K	1.13%	39
2021 Q4	$624K	Buy	20,496 +13,474	+192%	+$439K	0.53%	67
2021 Q3	$230K	Buy	+7,022	New	+$225K	0.2%	106

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Sippican Capital Advisors's OGN Position: Q2 2025 in Review

Sippican Capital Advisors sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 70,076 shares — an estimated $1.04M sold.

Sippican Capital Advisors first reported a position in OGN in Q3 2021 and held it in 14 quarters. The position peaked at $1.73M in Q2 2023. 694 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

Sippican Capital Advisors reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
Sippican Capital Advisors sold 70,076 Organon & Co shares in Q2 2025, an estimated $1.04M.
Sippican Capital Advisors first reported a position in Organon & Co in Q3 2021 and held it in 14 quarters.
Sippican Capital Advisors's Organon & Co position peaked at $1.73M in Q2 2023.
694 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Sippican Capital Advisors's 13F filing for Q2 2025, filed 25 Jul 2025.